BPN-15477 (Fig. 1a) increases full-length ELP1 mRNA by increasing exon 20 inclusion and is significantly more potent and efficacious than kinetin in our luciferase splicing assay (Fig. 1b,c) and  in FD patient cell lines (Fig. 1d). The gene discussed is ELP1; the disease is Fabry disease.